Vivos

#药闻简讯# $Vivos(VVOS)$ Therapeutics 发布儿童阻塞性睡眠呼吸暂停症里程碑式临床试验结果

$Vivos(VVOS)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001641172-25-010874  Act: 34  Size: 4 MB 网页链接

$Vivos(VVOS)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001641172-25-024832  Act: 34  Size: 6 MB 网页链接

$Vivos(VVOS)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001641172-25-024979  Act: 34  Size: 299 KB 网页链接

$Vivos(VVOS)$ 8-K/A [Amend] Current report, items 2.01, 8.01, and 9.01 Accession Number: 0001641172-25-025396  Act: 34  Size: 918 KB 网页链接

$Vivos(VVOS)$ 8-K Current report, items 1.01, 2.03, 3.02, 8.01, and 9.01 Accession Number: 0001641172-25-015115  Act: 34  Size: 1 MB 网页链接

摘要：Vivos Therapeutics 股价一夜飙升 22%，背后却隐藏着技术突破与盈利能力的巨大鸿沟。
一、开篇：
Vivos Therapeutics（NASDAQ:VVOS）昨晚股价飙升 22%，成交量放大至日均的 3 倍以上，表面看是市场对其 VidaSleep 口腔矫治器获 Medicare 批准的反应。但经营者视角下，这一事件暴露...

$Vivos(VVOS)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-25-024289  Act: 34  Size: 307 KB 网页链接

$Vivos(VVOS)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001493152-26-006829  Act: 33  Size: 588 KB 网页链接

$Vivos(VVOS)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001493152-26-014114  Act: 34  Size: 32 KB 网页链接

$Vivos(VVOS)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0002074003-25-000001  Size: 11 KB 网页链接

$Vivos(VVOS)$ 8-K Current report, items 4.01 and 9.01 Accession Number: 0001641172-25-014118  Act: 34  Size: 214 KB 网页链接

$Vivos(VVOS)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-25-013953  Act: 34  Size: 238 KB 网页链接

$Vivos(VVOS)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001641172-25-027210  Act: 34  Size: 490 KB 网页链接

$Vivos(VVOS)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001493152-26-002251  Act: 33  Size: 324 KB 网页链接

$Vivos(VVOS)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-002902  Act: 33  Size: 1 KB 网页链接

$Vivos(VVOS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0002074003-26-000008  Size: 15 KB 网页链接

$Vivos(VVOS)$ 2026年3月31日，V-Co Investors 3 LLC通过私募配售方式收购了Vivos Therapeutics, Inc. (VVOS)的1,353,625股普通股。此次收购代表了该公司10.0%的所有权权益。该交易是证券购买协议的一部分，包括2,390,000美元的认购金额，其中部分资金通过转换1,400,000美元的可转换本票提供。...

$Vivos(VVOS)$ 8-K Current report, item 5.07 Accession Number: 0001493152-25-020750  Act: 34  Size: 215 KB 网页链接

$Vivos(VVOS)$ NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB Accession Number: 0001493152-25-023404  Act: 34  Size: 33 KB 网页链接